In response to: Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
作者信息
Niranji Sherko S, Amin Al-Jaf Sirwan M
机构信息
College of Medicine, University of Garmian, Kalar, Iraq.
Coronavirus Research and Identification Lab, University of Garmian, Kalar, Iraq.
出版信息
J Med Virol. 2023 Jan;95(1):e28213. doi: 10.1002/jmv.28213. Epub 2022 Oct 17.
Abstract
摘要
相似文献
1
In response to: Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
J Med Virol. 2023 Jan;95(1):e28213. doi: 10.1002/jmv.28213. Epub 2022 Oct 17.
2
Comments on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".
J Med Virol. 2023 May;95(5):e28822. doi: 10.1002/jmv.28822.
3
Response to comments to the editor on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".
J Med Virol. 2023 May;95(5):e28820. doi: 10.1002/jmv.28820.
4
Reply to Letter to the Editor on disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
J Med Virol. 2023 Jan;95(1):e28313. doi: 10.1002/jmv.28313. Epub 2022 Nov 21.
5
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
6
7
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
8
Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.
Med. 2022 Jun 10;3(6):422-432.e3. doi: 10.1016/j.medj.2022.04.002. Epub 2022 Apr 14.
9
Corrigendum on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".
J Med Virol. 2023 May;95(5):e28824. doi: 10.1002/jmv.28824.
10
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.
Nat Med. 2022 Jul;28(7):1491-1500. doi: 10.1038/s41591-022-01816-0. Epub 2022 Apr 8.
本文引用的文献
1
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9.
2
Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq.
Mol Biol Rep. 2022 Aug;49(8):7437-7445. doi: 10.1007/s11033-022-07545-4. Epub 2022 Jun 13.
3
SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study).
Microb Pathog. 2022 Jul;168:105595. doi: 10.1016/j.micpath.2022.105595. Epub 2022 May 18.
4
Tracking SARS-CoV-2 variants by entire S-gene analysis using long-range RT-PCR and Sanger sequencing.
Clin Chim Acta. 2022 May 1;530:94-98. doi: 10.1016/j.cca.2022.03.014. Epub 2022 Mar 16.
5
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.
6
Multiplex PCR Assays for Identifying all Major Severe Acute Respiratory Syndrome Coronavirus 2 Variants.
J Mol Diagn. 2022 Apr;24(4):309-319. doi: 10.1016/j.jmoldx.2022.01.004. Epub 2022 Feb 2.
7
Development of New SNP Genotyping Assays to Discriminate the Omicron Variant of SARS-CoV-2.
Jpn J Infect Dis. 2022 Jul 22;75(4):411-414. doi: 10.7883/yoken.JJID.2022.007. Epub 2022 Jan 31.
8
Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants.
Med Microbiol Immunol. 2022 Feb;211(1):71-77. doi: 10.1007/s00430-022-00728-7. Epub 2022 Jan 21.
9
SARS-CoV-2 multiplex RT-PCR to detect variants of concern (VOCs) in Malaysia, between January to May 2021.
J Virol Methods. 2022 Mar;301:114462. doi: 10.1016/j.jviromet.2022.114462. Epub 2022 Jan 10.
10
Molecular detection of SARS-CoV-2 strains and differentiation of Delta variant strains.
Transbound Emerg Dis. 2022 Sep;69(5):2879-2889. doi: 10.1111/tbed.14443. Epub 2022 Jan 5.
Zotero 插件